A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Histocompatibility Laboratory Bookmark and Share

Histocompatibility Laboratory

The Histocompatibility Laboratory at City of Hope provides the highest standard of human leukocyte antigen typing services on a contract basis, as well as for City of Hope’s Department of Hematology & Hematopoietic Cell Transplantation. In operation since 1975, our clientele includes a number of prominent institutions such as Kaiser Permanente of Southern California, Loyola University in Chicago, BloodSource and the University of California at Davis, among others. The Histocompatibility Laboratory is staffed by specially trained technologists and utilizes state-of-the-art technology in the field of histocompatibility.
 
High Quality Service and Rapid Response
City of Hope’s Histocompatibility Laboratory maintains high quality service and rapid response times. With the exception of unique circumstances, we communicate HLA typing results within a maximum of ten (10) working days upon receipt of a blood specimen. Results of histocompatibility testing can be reported by phone, fax or email as soon as they are available, and will be followed by an official written report.
 
Licenses and Accreditations
City of Hope’s Histocompatibility Laboratory is fully accredited by The American Society of Histocompatibility and Immunogenetics (ASHI), College of American Pathologists (CAP), and Clinical Laboratory Improvement Amendments (CLIA 88).
 
The laboratory holds the following licenses:
  • CLIA #05D0665695
  • CA State License #209978

HLA and Stem Cell Transplantation

This page explains the field of “HLA,” its role in stem cell transplantation and some relevant terminology. It also addresses the blood tests your doctor will order before a stem cell transplant, and the useful information the blood sample provides.
 
Stem Cell Transplants
In order to treat certain diseases, it is necessary to give whole body irradiation and high dose chemotherapy. While this therapy destroys malignant cells, unfortunately it also destroys the cells responsible for generating red blood cells, white blood cells and platelets. In order for the patient to survive after radiation and chemotherapy, these cells (called “hematopoietic stem cells”) must be transfused back into the patient. They then migrate to the bone marrow, divide, and eventually produce new blood cells and platelets.

There are three main sources of hematopoietic stem cells. Stem cells that circulate throughout the blood stream are called “peripheral blood stem cells” or PBSCs. Another source is the bone marrow, where most stem cells reside. A third source of stem cells is the umbilical cord of a newborn baby.

If the hematopoietic stem cells transfused into the patient are from another individual, it is best if the cells carry the same HLA molecules as the patient – otherwise, the patient may either reject the stem cell transplant or the transplanted stem cells may react to the patient’s tissues in what is termed “graft versus host disease.”
 
What is HLA?
HLA stands for “Human Leukocyte Antigen.” These are protein molecules that we inherit from our parents. We currently know about nearly 600 different HLA molecules. Before you have a stem cell transplant, your HLA type must be determined. This is done by taking a blood sample.

The laboratory will also determine the HLA type of anyone who may donate stem cells to you. It is important in stem cell transplants to see how closely the HLA of the transplant patient matches the HLA of the stem cell donor. The HLA “match” is the number of HLA molecules that any two people have in common. HLA matching is usually based on six HLA molecules. The more molecules two people share, the better the match. When two individuals share the same HLA type, they are said to be a good match. That is, their immune systems will not see each other as “foreign” and are less likely to attack each other.

The most likely place to find an HLA match between two people is among siblings (brothers and sisters who have the same mother and same father). If two siblings inherit the very same HLA molecules from both parents, they are said to be an “HLA identical match.”

You have a 25 percent (1 in 4) chance of being an HLA identical match with your sibling. Why? Because there is a basic rule in HLA inheritance: you have a 25 percent chance of inheriting the same HLA molecules as your sibling, a 25 percent chance of inheriting none of the same HLA molecules as your sibling, and a 50 percent chance of inheriting half of the same HLA molecules as your sibling.

However, two unrelated people can just happen to be a good HLA match, too. Although it is less likely, it is possible that you could have some of the same HLA molecules as a friend or as someone you don’t even know. If you and your friend share three HLA molecules, for example, then you are said to be a “three HLA antigen match.”

Finding the Best Match
When a doctor decides that a stem cell transplant is the best treatment for a patient, he or she will request a family study. The patient, all of his or her siblings, and usually their parents will have their blood drawn for HLA typing. If one of the family members is an HLA identical match, the lab will do further testing to be absolutely sure that they are the best match possible. This usually involves taking the patient’s and the donor’s DNA from the blood cells and typing the HLA genes to show that they are identical.

If none of the siblings or the parents are a good HLA match, the doctor will sometimes ask to have additional family members tested. These are usually aunts, uncles, cousins and grandparents. If it happens that there are no close HLA matches within the patient’s family,a search will be initiated for an unrelated donor with the same HLA molecules as the patient.
 
Glossary of HLA Terms
  • HLA: human leukocyte antigen, proteins we inherit from our parents
  • HLA Matching: the number of HLA molecules two people have in common
  • HLA Antibodies: proteins in the patient's blood against the donor's HLA that could attack transplanted or transfused cells
  • PRA: panel reactive antibody, a measure of how much HLA antibody the patient has
  • Stem Cell: cells responsible for generating red blood cells, white blood cells, and platelets
  • Red Blood Cell: the cells that carry oxygen to all parts of the body
  • White Blood Cell: the cells of the immune system that fight off germs
  • Platelets: the cells that form clots to stop bleeding
  • Bone Marrow: the inner spongy portion of large bones, where most stem cells reside
  • Graft versus Host Disease: an immune attack by transplanted donor cells against the patient’s body
  • ABO: blood type, a person can be A, B, AB or O blood type

Available Tests

In addition to standard typing as itemized in the chart below, City of Hope's Histocompatiblity Laboratory now offers:

Tests                                                          Methodology
 
HLA-AB Typing                                                               Luminex
 
Donor/Recipient Crossmatch                                    Serology
 
HLA Antibody Screening                                              Serology/SSOP
 
B27 Typing                                                                      PCR-SSP/SBT
 
HLA-ABC Low Resolution Typing                               SSOP
 
HLA-DRB1, DQB1 Low Resolution Typing               SSOP
 
HLA-ABC High Resolution Typing                              PCR-SSP or SBT
 
HLA-DRB1, DPB1, DQB1 High ResolutionTyping  PCR-SSP or SBT

Engraftment Analysis                                                   Short Tandem Repeat
 
 
 
Fees for tests will be provided upon request.
 

Specimen Requirements

Please adhere to these instructions for sampling and labeling.
 
Requisition Form
  • Download the requisition form here in Adobe Acrobat (.pdf) format. If you don't have Adobe Acrobat Reader, you can download it for free here.
  • Specimens should be sent with a completed requisition form for overnight delivery using proper handling techniques.
  • Include completed HLA Laboratory requisition form with shipment.
  • Call the laboratory at (877) 443-GENE (4363) upon shipping the specimens.
 
Before the Specimen is Drawn
  • Call the laboratory at (877) 443-GENE (4363) to schedule testing.
 
Drawing and Storing Specimen for Shipment
  • 5-10 cc of blood should be drawn and immediately transferred into 1 yellow tope tubes (ACD Solution A) and one red top tube.
  • Mix well by inverting tubes several times.
  • Store specimen at room temperature.
  • Include completed HLA Laboratory requisition form with shipment.
     
Labeling Specimen
  • Please label each sample with the following information:
  • Date blood was drawn
  • Name, birthday, race and patient’s I.D. number
  • Recipient/donor relationship
 
 

Contact Us

For more information or to request a test, please contact us via:

Phone: 877-443-GENE (4363)
Fax: 626-301-8888
Email: dsenitzer@coh.org

City of Hope
Attention: Histocompatibility Laboratory
1500 E. Duarte Road
Duarte, CA 91010

Directions and Maps

Histocompatibility Laboratory

Histocompatibility Laboratory

The Histocompatibility Laboratory at City of Hope provides the highest standard of human leukocyte antigen typing services on a contract basis, as well as for City of Hope’s Department of Hematology & Hematopoietic Cell Transplantation. In operation since 1975, our clientele includes a number of prominent institutions such as Kaiser Permanente of Southern California, Loyola University in Chicago, BloodSource and the University of California at Davis, among others. The Histocompatibility Laboratory is staffed by specially trained technologists and utilizes state-of-the-art technology in the field of histocompatibility.
 
High Quality Service and Rapid Response
City of Hope’s Histocompatibility Laboratory maintains high quality service and rapid response times. With the exception of unique circumstances, we communicate HLA typing results within a maximum of ten (10) working days upon receipt of a blood specimen. Results of histocompatibility testing can be reported by phone, fax or email as soon as they are available, and will be followed by an official written report.
 
Licenses and Accreditations
City of Hope’s Histocompatibility Laboratory is fully accredited by The American Society of Histocompatibility and Immunogenetics (ASHI), College of American Pathologists (CAP), and Clinical Laboratory Improvement Amendments (CLIA 88).
 
The laboratory holds the following licenses:
  • CLIA #05D0665695
  • CA State License #209978

HLA and Stem Cell Transplantation

HLA and Stem Cell Transplantation

This page explains the field of “HLA,” its role in stem cell transplantation and some relevant terminology. It also addresses the blood tests your doctor will order before a stem cell transplant, and the useful information the blood sample provides.
 
Stem Cell Transplants
In order to treat certain diseases, it is necessary to give whole body irradiation and high dose chemotherapy. While this therapy destroys malignant cells, unfortunately it also destroys the cells responsible for generating red blood cells, white blood cells and platelets. In order for the patient to survive after radiation and chemotherapy, these cells (called “hematopoietic stem cells”) must be transfused back into the patient. They then migrate to the bone marrow, divide, and eventually produce new blood cells and platelets.

There are three main sources of hematopoietic stem cells. Stem cells that circulate throughout the blood stream are called “peripheral blood stem cells” or PBSCs. Another source is the bone marrow, where most stem cells reside. A third source of stem cells is the umbilical cord of a newborn baby.

If the hematopoietic stem cells transfused into the patient are from another individual, it is best if the cells carry the same HLA molecules as the patient – otherwise, the patient may either reject the stem cell transplant or the transplanted stem cells may react to the patient’s tissues in what is termed “graft versus host disease.”
 
What is HLA?
HLA stands for “Human Leukocyte Antigen.” These are protein molecules that we inherit from our parents. We currently know about nearly 600 different HLA molecules. Before you have a stem cell transplant, your HLA type must be determined. This is done by taking a blood sample.

The laboratory will also determine the HLA type of anyone who may donate stem cells to you. It is important in stem cell transplants to see how closely the HLA of the transplant patient matches the HLA of the stem cell donor. The HLA “match” is the number of HLA molecules that any two people have in common. HLA matching is usually based on six HLA molecules. The more molecules two people share, the better the match. When two individuals share the same HLA type, they are said to be a good match. That is, their immune systems will not see each other as “foreign” and are less likely to attack each other.

The most likely place to find an HLA match between two people is among siblings (brothers and sisters who have the same mother and same father). If two siblings inherit the very same HLA molecules from both parents, they are said to be an “HLA identical match.”

You have a 25 percent (1 in 4) chance of being an HLA identical match with your sibling. Why? Because there is a basic rule in HLA inheritance: you have a 25 percent chance of inheriting the same HLA molecules as your sibling, a 25 percent chance of inheriting none of the same HLA molecules as your sibling, and a 50 percent chance of inheriting half of the same HLA molecules as your sibling.

However, two unrelated people can just happen to be a good HLA match, too. Although it is less likely, it is possible that you could have some of the same HLA molecules as a friend or as someone you don’t even know. If you and your friend share three HLA molecules, for example, then you are said to be a “three HLA antigen match.”

Finding the Best Match
When a doctor decides that a stem cell transplant is the best treatment for a patient, he or she will request a family study. The patient, all of his or her siblings, and usually their parents will have their blood drawn for HLA typing. If one of the family members is an HLA identical match, the lab will do further testing to be absolutely sure that they are the best match possible. This usually involves taking the patient’s and the donor’s DNA from the blood cells and typing the HLA genes to show that they are identical.

If none of the siblings or the parents are a good HLA match, the doctor will sometimes ask to have additional family members tested. These are usually aunts, uncles, cousins and grandparents. If it happens that there are no close HLA matches within the patient’s family,a search will be initiated for an unrelated donor with the same HLA molecules as the patient.
 
Glossary of HLA Terms
  • HLA: human leukocyte antigen, proteins we inherit from our parents
  • HLA Matching: the number of HLA molecules two people have in common
  • HLA Antibodies: proteins in the patient's blood against the donor's HLA that could attack transplanted or transfused cells
  • PRA: panel reactive antibody, a measure of how much HLA antibody the patient has
  • Stem Cell: cells responsible for generating red blood cells, white blood cells, and platelets
  • Red Blood Cell: the cells that carry oxygen to all parts of the body
  • White Blood Cell: the cells of the immune system that fight off germs
  • Platelets: the cells that form clots to stop bleeding
  • Bone Marrow: the inner spongy portion of large bones, where most stem cells reside
  • Graft versus Host Disease: an immune attack by transplanted donor cells against the patient’s body
  • ABO: blood type, a person can be A, B, AB or O blood type

Available Tests

Available Tests

In addition to standard typing as itemized in the chart below, City of Hope's Histocompatiblity Laboratory now offers:

Tests                                                          Methodology
 
HLA-AB Typing                                                               Luminex
 
Donor/Recipient Crossmatch                                    Serology
 
HLA Antibody Screening                                              Serology/SSOP
 
B27 Typing                                                                      PCR-SSP/SBT
 
HLA-ABC Low Resolution Typing                               SSOP
 
HLA-DRB1, DQB1 Low Resolution Typing               SSOP
 
HLA-ABC High Resolution Typing                              PCR-SSP or SBT
 
HLA-DRB1, DPB1, DQB1 High ResolutionTyping  PCR-SSP or SBT

Engraftment Analysis                                                   Short Tandem Repeat
 
 
 
Fees for tests will be provided upon request.
 

Specimen Requirements

Specimen Requirements

Please adhere to these instructions for sampling and labeling.
 
Requisition Form
  • Download the requisition form here in Adobe Acrobat (.pdf) format. If you don't have Adobe Acrobat Reader, you can download it for free here.
  • Specimens should be sent with a completed requisition form for overnight delivery using proper handling techniques.
  • Include completed HLA Laboratory requisition form with shipment.
  • Call the laboratory at (877) 443-GENE (4363) upon shipping the specimens.
 
Before the Specimen is Drawn
  • Call the laboratory at (877) 443-GENE (4363) to schedule testing.
 
Drawing and Storing Specimen for Shipment
  • 5-10 cc of blood should be drawn and immediately transferred into 1 yellow tope tubes (ACD Solution A) and one red top tube.
  • Mix well by inverting tubes several times.
  • Store specimen at room temperature.
  • Include completed HLA Laboratory requisition form with shipment.
     
Labeling Specimen
  • Please label each sample with the following information:
  • Date blood was drawn
  • Name, birthday, race and patient’s I.D. number
  • Recipient/donor relationship
 
 

Contact Us

Contact Us

For more information or to request a test, please contact us via:

Phone: 877-443-GENE (4363)
Fax: 626-301-8888
Email: dsenitzer@coh.org

City of Hope
Attention: Histocompatibility Laboratory
1500 E. Duarte Road
Duarte, CA 91010

Directions and Maps

Patient Care Overview

City of Hope Locations

Faces of Cancer

Meet City of Hope patients and their families.
 
 
Clinics/Treatments/Services
As a Comprehensive Cancer Center – the highest designation given by the National Cancer Institute – we are widely regarded as a leader in cancer prevention and treatment.

Cancer Expertise Matters


NEWS & UPDATES
  • The physical side effects of cancer can damage anyone’s self-confidence, but especially that of women who, rightly or wrongly, are more likely to find their appearance (or their own perception of their appearance) directly connected to their ability to face the world with something resembling ap...
  • The promise of stem cell therapy has long been studied in laboratories. Now, as medicine enters an era in which this therapy will be increasingly available to patients, the nurses who help deliver it will be in the spotlight. City of Hope, which has launched its Alpha Clinic for Cell Therapy and Innovation (ACT...
  • Just because you can treat a condition, such as high cholesterol, at the end of life — well, that doesn’t mean you should. That’s the basic lesson of a study to be published March 30 in JAMA Internal Medicine. The ramifications go far beyond that. The research, in which City of Hope’s Betty Fe...
  • The understanding of the relationship between genetics and cancer risk continues to grow, with more genetic testing than ever before available to patients. However, the adage that a little knowledge is a dangerous thing is applicable: Without context for what a test result means, and without meaningful guidance...
  • Standard prostate biopsies haven’t changed significantly in the past 30 years – nor have the problems inherent with them. Regular biopsies have an expected error rate: Tumors may potentially be undersampled and, 30 percent of the time, men who undergo a radical prostatectomy are found to have more aggress...
  • In the field of cancer, patients have had surgery, chemotherapy and radiation therapy as options. Now, as City of Hope officially opens the Alpha Clinic for Cellular Therapy and Innovation, patients battling cancer and other life-threatening diseases have another option: stem-cell-based therapy. The Alpha Clini...
  • How does the environment affect our health? Specifically, how does it affect our risk of cancer? City of Hope physicians and researchers recently answered those questions in an Ask the Experts event in Corona, California, explaining the underlying facts about how the environment can affect our health. Moderator...
  • Nurses and other medical professionals have come to understand that it’s not enough just to fight disease. They also must provide pain relief, symptom control, and an unrelenting commitment to improve patients’ quality of life — especially at the end of life. Not too long ago, this was a relatively ...
  • “Tonight, I’m launching a new precision medicine initiative to bring us closer to curing diseases like cancer.” These were the words of President Barack Obama on Jan. 20, 2015, during his State of the Union address. So what is precision medicine, and how close are we to making it a reality for...
  • March is Colon Cancer Awareness Month. How sad, yet how serendipitous, that the co-creator of “The Simpsons” Sam Simon passed away in March after a four-year battle against colon cancer. What message can we all learn from his illness that can help us prevent and overcome colon cancer in our own lives? Colon can...
  • Misagh Karimi, M.D., assistant clinical professor, is a medical oncologist at one of City of Hope’s newest community practice locations, located in Corona in Riverside County. A recent community health report from Corona’s public health department stated that obesity rates for teens and adults in Riverside Coun...
  • In 1975, the median survival for patients with ovarian cancer was about 12 months. Today, the median survival is more than 5 years. Although researchers and clinicians are far from satisfied, the progress in ovarian cancer treatment is encouraging, said Robert Morgan, M.D., F.A.C.P., professor of medical oncolo...
  • Colorectal cancer may be one of the most common cancers in both men and women, but it’s also one of the most curable cancers. Today, because of effective screening tests and more advanced treatment options, there are more than 1 million survivors of colorectal cancer in the United States. Here, colorectal...
  • Breast cancer treatment can damage a woman’s ability to become pregnant, making the impact on fertility one of the key factors that many consider when choosing a therapy regimen. Now a study has found that breast cancer patients treated with a hormone-blocking drug in addition to chemotherapy were less li...
  • My colleagues in the clinic know I’ve got a soft spot. Last week, a patient of mine offered me a fantastic compliment. “You’re looking younger these days, Dr. Pal!” she said, offering me a big hug as she proceeded out of the clinic room. Lovely, I thought. The early morning workouts are paying off. She continue...